{
    "date": "2025-04-29",
    "news": [
        {
            "title": "White House blasts Amazon over tariff cost report: 'Hostile and political act'",
            "link": "https://www.cnbc.com/2025/04/29/white-house-blasts-amazon-over-tariff-cost-report-hostile-and-political-act.html",
            "summary": "The White House slammed Amazon for reportedly planning to display the cost of President Donald Trump's tariffs next to the total price of products on its site.",
            "date": "Tue, 29 Apr 2025 13:26:18 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "WCP.TO",
            "impact": "Neutral"
        },
        {
            "title": "General Motors beats Wall Street estimates, reassesses full-year guidance amid auto tariffs",
            "link": "https://www.cnbc.com/2025/04/29/general-motors-gm-earnings-q1-2025.html",
            "summary": "GM beat expectations but is reassessing its 2025 guidance. GM is suspending any additional stock buybacks amid expected cost increases and industry uncertainty. GM beat expectations in its latest quarter.",
            "date": "Tue, 29 Apr 2025 11:58:16 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "GM",
            "impact": "Neutral"
        },
        {
            "title": "Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%",
            "link": "https://www.cnbc.com/2025/04/29/novo-nordisk-wegovy-telehealth.html",
            "summary": "Many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions. Novo Nordisk is racing to capture more patients.",
            "date": "Tue, 29 Apr 2025 13:17:17 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "NOVO-B.CO",
            "impact": "Neutral"
        },
        {
            "title": "Coke keeps full-year forecast, says it expects tariff disruptions to be 'manageable' after Pepsi cuts earnings outlook",
            "link": "https://www.cnbc.com/2025/04/29/coca-cola-ko-q1-2025-earnings.html",
            "summary": "Coke beat first-quarter earnings estimates, and unlike rival Pepsi, maintained its full-year outlook. The company expects cost hikes from tariffs to be \"manageable\"",
            "date": "Tue, 29 Apr 2025 12:38:14 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "COKE",
            "impact": "Neutral"
        },
        {
            "title": "Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall",
            "link": "https://www.cnbc.com/2025/04/29/pfizer-pfe-earnings-q1-2025.html",
            "summary": "Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy. Pfizer: \"We are unable to predict at this time\"",
            "date": "Tue, 29 Apr 2025 11:51:52 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "PFE",
            "impact": "Neutral"
        },
        {
            "title": "Hims & Hers’ stock rockets after teaming up with its rival Wegovy maker",
            "link": "https://www.marketwatch.com/story/hims-hers-stock-rockets-after-teaming-up-with-its-rival-wegovy-maker-c53131e1?mod=mw_rss_topstories",
            "summary": "Health and wellness company Hims & Hers sells alternatives to weight-loss drugs like Wegovy. Hems & Hers is now collaborating with the maker of WeGovy.",
            "date": "Tue, 29 Apr 2025 13:13:00 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "HIMS",
            "impact": "Neutral"
        },
        {
            "title": "‘I’m literally afraid to look at my balance’: I have $300K in a 2025 target-date fund. Is there a chance it will recover?",
            "link": "https://www.marketwatch.com/story/im-literally-afraid-to-look-at-my-balance-i-have-300k-in-a-2025-target-date-fund-is-there-a-chance-it-will-recover-8765e9ca?mod=mw_rss_topstories",
            "summary": "“I have no idea at this point how much I have lost,” he says. “I’ve lost a lot. I’m in shock.”",
            "date": "Tue, 29 Apr 2025 13:08:00 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "IBRX",
            "impact": "Neutral"
        },
        {
            "title": "If you love gold at near record high prices, why not wear it?",
            "link": "https://www.marketwatch.com/story/if-you-love-gold-at-near-record-high-prices-why-not-wear-it-e385e1c4?mod=mw_rss_topstories",
            "summary": "Gold jewelry can increasingly be appealing for investors. ‘I buy it as a kind of fun way to enjoy the gold you own’",
            "date": "Tue, 29 Apr 2025 13:00:00 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "IFF",
            "impact": "Neutral"
        },
        {
            "title": "Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID",
            "link": "https://www.marketwatch.com/story/pfizers-plunging-paxlovid-sales-impact-revenue-as-covid-fades-48a8e487?mod=mw_rss_topstories",
            "summary": "Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”",
            "date": "Tue, 29 Apr 2025 12:46:00 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "PFE",
            "impact": "Neutral"
        },
        {
            "title": "Spotify earnings come up short as it warns of short-term noise",
            "link": "https://www.marketwatch.com/story/spotify-earnings-come-up-short-as-it-warns-of-short-term-noise-fe27aa1f?mod=mw_rss_topstories",
            "summary": "Spotify missed on earnings and guided for more \"noise\" to come. The company's stock dropped sharply in premarket trade on Tuesday.",
            "date": "Tue, 29 Apr 2025 12:44:00 GMT",
            "tags": [
                "Finance",
                "Stocks"
            ],
            "stock_ticker": "SPOT",
            "impact": "Neutral"
        }
    ]
}